Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-25T09:10:35.488Z Has data issue: false hasContentIssue false
  • English
  • Français

Pharmacological Treatment of Agoraphobia

Imipramine versus Imipramine with Programmed Practice

Published online by Cambridge University Press:  29 January 2018

Matig Mavissakalian ,
Larry Michelson  and
Robert S. Dealy
Matig Mavissakalian
Affiliation:
University of Pittsburgh School of Medicine, Department of Psychiatry, Western Psychiatric Institute and Clinic, 3811 O'Hara Street, Pittsburgh, Pennsylvania 15213
Larry Michelson
Affiliation:
University of Pittsburgh School of Medicine, Department of Psychiatry, Western Psychiatric Institute and Clinic, 3811 O'Hara Street, Pittsburgh, Pennsylvania 15213
Robert S. Dealy
Affiliation:
University of Pittsburgh School of Medicine, Department of Psychiatry, Western Psychiatric Institute and Clinic, 3811 O'Hara Street, Pittsburgh, Pennsylvania 15213
Get access Rights & Permissions [Opens in a new window]

Summary

Eighteen agoraphobic patients were randomly assigned to 12 week treatment with imipramine (I) or imipramine and programmed in-vivo exposure practice (l+BT) to investigate the contribution of behavioural instructions to the clinical effects of pharmacotherapy. Significantly greater improvement on phobic measures was found in the l+BT group compared to the I group. Differences were less marked on measures of panic and anxiety. The results suggest that imipramine possesses an antiphobic effect which can be substantially enhanced with programmed practice. Controlled large-scale investigations of the pharmacological and instructional effects of the pharmacotherapy of agoraphobia are needed for a definitive evaluation of the specific antiphobic effect of antidepressant drugs.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 143 , Issue 4 , October 1983 , pp. 348 - 355
Copyright
Copyright © 1983 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (DSM-III) (3rd ed.). Washington, DC.Google Scholar
Appleby, I. L., Klein, D. F., Sachar, E. J. & Levitt, M. (1981) Biochemical indices of lactate-induced panic: A preliminary report. In Anxiety: New Research and Changing Concepts (eds. Klein, D. F. and Rabkin, J.). New York: Raven Press.Google Scholar
Bandura, A. (1977) Self-efficacy: Towards a unifying theory of behavioral change. Psychological Review, 84, 191–215.Google Scholar
Beck, A. T., Ward, C. H., Mendelson, M., Mock, J. & Erbaugh, J. (1961) An inventory for measuring depression. Archives of General Psychiatry, 4, 53–63.Google Scholar
Goldstein, A. J. & Chambless, D. L. (1978) A reanalysis of agoraphobia. Behavior Therapy, 9, 47–59.CrossRefGoogle Scholar
Greist, J., Marks, I. M., Berlin, F., Gournay, K. & Noshirvani, H. (1980) Avoidance versus confrontation of fear. Behavior Therapy, 11, 1–14.CrossRefGoogle Scholar
Hallam, R. S. (1978) Agoraphobia: A critical review of the concept. British Journal of Psychiatry, 133, 314–19.CrossRefGoogle ScholarPubMed
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.Google Scholar
Jannoun, L., Munby, M., Catalan, J. & Gelder, M. (1980) A home-based treatment program for agoraphobia: Replication and controlled evaluation. Behavior Therapy, 11, 294–305.Google Scholar
Jansson, L. & Ost, L. (1982) Behavioral treatment for agoraphobia: An evaluative review. Clinical Psychology Review, 2, 311–36.CrossRefGoogle Scholar
Kelly, D., Mitchell-Heggs, N. & Sherman, D. (1971) Anxiety in the effects of sodium lactate assessed clinically and physiologically. British Journal of Psychiatry, 119, 468–70.Google Scholar
Klein, D. F. (1981) Anxiety reconceptualized. In Anxiety: New Research and Changing Concepts (eds. Klein, D. F. and Rabkin, J.). New York: Raven Press.Google Scholar
Klein, D. F., Zitrin, C. M., Woerner, M. G. & Ross, D. C. (1983) Treatment of phobias: II. Behavior therapy and supportive psychotherapy: Are there any specific ingredients? Archives of General Psychiatry, 40, 139–45.Google Scholar
Lader, M. H. (1978) Physiological research in anxiety. In Research in Neurosis (ed. van Praag, H. M.). New York: SP Medical and Scientific Books.Google Scholar
Liebowitz, M. R. & Klein, D. F. (1982) Agoraphobia: Clinical features, pathophysiology, and treatment. In Agoraphobia: Multiple Perspectives on Theory and Treatment (eds. Chambless, D. L. and Goldstein, A. J.). New York: John Wiley.Google Scholar
Marks, I. M. (1969) Fears and Phobias. London: Heinemann.Google Scholar
Marks, I. M. (1981) Are there anticompulsive or antibiotic drugs? Review of the evidence. Paper presented to ACNP, San Diego, December.Google Scholar
Marks, I. M. & Gelder, M. G. (1965) A controlled retrospective study of behavior therapy in phobic patients. British Journal of Psychiatry, 111, 561–73.Google Scholar
Marks, I. M., Gray, S., Cohen, D., Hill, R., Mawson, D., Ramm, E. & Stern, R. S. (1983) Imipramine and brief therapist-aided exposure in agoraphobics having self-exposure homework. Archives of General Psychiatry, 40, 153–62.CrossRefGoogle ScholarPubMed
Marks, I. M. & Mathews, A. M. (1979) Brief standard self-rating for phobic patients. Behaviour Research and Therapy, 17, 263–7.Google Scholar
Mathews, A. M., Gelder, M. G. & Johnston, D. W. (1981) Agoraphobia: Nature and Treatment. New York: Guilford Press.Google Scholar
Mathews, A. M., Teasdale, J., Munby, M., Johnston, D. & Shaw, P. (1977) A home-based treatment program for agoraphobia. Behavior Therapy, 8, 915–24.CrossRefGoogle Scholar
Mavissakalian, M. (1982) Pharmacologic treatment of anxiety disorders. Journal of Clinical Psychiatry, 43, 487–91.Google Scholar
Mavissakalian, M. (1983) Antidepressants in the treatment of agoraphobia and obsessive-compulsive disorder. Comprehensive Psychiatry, (in press).Google Scholar
Mavissakalian, M. & Barlow, D. H. (1981) Phobia: Psychological and Pharmacological Treatment. New York: Guilford Press.Google Scholar
Mavissakalian, M. & Michelson, L. (1982) Agoraphobia: Behavioral and pharmacological treatments, preliminary outcome, and process findings. Psychopharmacology Bulletin, 18, 91–103.Google ScholarPubMed
Mavissakalian, M. & Michelson, L. (1983a) Agoraphobia: Behavioral and pharmacological treatment. N = 49. Psychopharmacology Bulletin, 19, 116–18.Google Scholar
Mavissakalian, M. & Michelson, L. (1983b) (Submitted for publication). Agoraphobia: Behavioral and pharmacological treatment.Google Scholar
McDonald, R., Sartory, G., Grey, S. J., Cobb, J., Stern, R. & Marks, I. M. (1979) The effects of self-exposure instructions on agoraphobic outpatients. Behaviour Research and Therapy, 17, 1183–5.CrossRefGoogle Scholar
McNair, D. M. & Kahn, R. J. (1981) Imipramine compared with a benzodiazepine for agoraphobia. In Anxiety: New Research and Changing Concepts (eds. Klein, D. F. and Rabkin, J. G.). New York: Raven Press.Google Scholar
Sheehan, D. V., Ballenger, J. & Jacobsen, G. (1980) Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Archives of General Psychiatry, 37, 51–9.CrossRefGoogle ScholarPubMed
Snaith, R. P. A. (1968) A clinical investigation of phobias. British Journal of Psychiatry, 114, 673–9.Google Scholar
Solyom, C., Solyom, L., LaPierre, Y., Pecknold, J. & Morton, L. (1981) Phenelzine and exposure in the treatment of phobias. Biological Psychiatry, 3, 239–47.Google Scholar
Watson, J. P. & Marks, I. M. (1971) Relevant and irrelevant fear in flooding: A crossover study of phobic patients. Behavior Therapy, 2, 275–95.CrossRefGoogle Scholar
Zitrin, C. M., Klein, D. F., Woerner, M. G. & Ross, D. C. (1983) Treatment of phobias: I. Comparison of imipramine hydrochloride and placebo. Archives of General Psychiatry, 40, 125–38.CrossRefGoogle ScholarPubMed
Zung, W. W. K. (1971) A rating instrument for anxiety disorders. Psychosomatics, 12, 371–9.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.